Author: TroyFlowers

Cara Therapeutics Announces Top-line Results From Phase 2b Trial of Oral CR845 in Chronic Pain Patients With Osteoarthritis of the Hip or Knee

SHARE THIS POST Statistically significant 39 percent reduction in mean joint pain score in hip patients at eight weeks with 5.0 mg dose 35 percent reduction in mean joint pain score for all patients at eight weeks with 5.0 mg dose – All tablet strengths well tolerated over eight-week treatment period – Conference call today at 4:30 p.m. ET – STAMFORD, Conn., June 29, 2017 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting peripheral kappa opioid receptors, today announced top-line...

Read More

Cannabis Science Calls on All MMJ Companies to Recognize and Join the Fight Against Opioid Addiction and Deaths by Supporting Self-Medicating Patients to fight Opioid Abuse by Using all Forms of Ingested MMJ as a Viable Gateway out of Extreme Opioid Usage

SHARE THIS POST JAMA Internal Medicine Published an Astounding 25% Drop in Opioid Overdose Deaths in States with Medical Cannabis Laws on the Books for MMJ Self-Medicating Patient Usage IRVINE, CA–(Marketwired – Jun 28, 2017) –  Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, calls on all MMJ Companies to recognize and join in the fight against Opioid Addiction and Deaths by educating and supporting their self-medicating patients to fight opioid over-usage by using all forms of ingested MMJ as a Gateway out of Extreme Opioid Usage. Last fall, a study published...

Read More

Alliance Growers Updates Market Potential for Botany Center Sales

SHARE THIS POST June 29, 2017 – Vancouver, B.C. – Alliance Growers Corp. (CSE: ACG; FWB: 1LA; WKN: A2DFYX) (“Alliance Growers” or the “Company”) announces updated potential market for tissue cultured marijuana clone plantlets to be produced at the Cannabis Botany Centre and an update on financing activities. Alliance Growers is continually updating the potential market for tissue cultured marijuana clone plantlets utilizing published data of the annual plants required by licensed growers.  According to recent published data, dedicated grow-out space of the top 50 percent of Licensed ACMPR producers require 7,300,000 plants currently with ongoing expansion to 16,000,000...

Read More

Medical Marijuana Regulations Bill Signed by Florida Governor, Yet Problems Remain

Getty Last week, Florida Governor Rick Scott finally signed a bill that puts regulations in place for Amendment 2, the measure voters in the state approved last November; a measure that greatly expanded the state’s small medical marijuana program. The path to those regulations was a long and contentious one. And the battle is far from over. “This is a good day for sick and suffering Floridians. The signing of this law provides a framework for the future of our state’s medical marijuana system and while it is far from perfect, it will begin providing access to patients,” said...

Read More

Canada Could See a Shortage of Legal Cannabis

Getty It’s been a little over a year since Canadian Prime Minister Justin Trudeau announced his plan to legalize the recreational use of cannabis nationwide. Now, they have unveiled legislation that would do so, but they are running into another potential problem – a shortage of cannabis to sell. With the growing medical marijuana industry – and the rapid growth of the patient base in the last year since the announcement about legalizing recreational marijuana – the limited suppliers are having a hard time keeping up. This could end up being a big problem for the country who hopes...

Read More

New Poll Finds Most Americans Want Legal Marijuana Left Alone

Getty A new survey commissioned by the cannabis law reform advocacy organization Marijuana Majority and conducted by Survey USA shows that a clear majority of Americans support letting states decide their own marijuana policies, free from federal government interference. Some 76% of respondents said they want to see states that pass marijuana law reform measures left alone by the feds, while only 14% think the Trump Administration should intervene. These are numbers that are sure to be quite surprising to Attorney General Jeff Sessions. That large majority holds up across all races, age groups and party affiliations, including those...

Read More